Gregory M Weinhoff
CIK 1400975 · Chief Business Officer · last filed 2026-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CNTA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
3RD FL., 1 ASHLEY RD, ALTRINCHAM
CHESHIRE, X0 WA14 2DT
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc (CNTA) Delisted | Chief Business Officer | 0 | $40.50 | $0 | -$5.64M | 36 | 2026-06-24 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Director | 2,058,555 | $14.49 | $29.83M | -$850.0K | 3 | 2008-08-18 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| FOLD | By CHL Medical Partners II, L.P. | 1,928,612 | 93.7% | 2008-08-18 |
| By CHL Medical Partners II Side Fund, L.P. | 129,943 | 6.3% | 2008-08-18 | |
| Total | 2,058,555 | |||
| No longer reported | ||||
| By Partnership | 2,108,555 | — | last 2007-06-07 | |
Recent Filings · Page 2 of 6
60 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-27 | Centessa Pharmaceuticals plc | Notice (144) Officer · Planned May 27, 2025 · 10b5-1 plan Sold: listed on the Jun 25, 2025 notice |
−10,000 | -$128.2K | EDGAR |
| 2025-05-27 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed10b5-1 Plan adopted May 22, 2024 |
— | -$89.7K | EDGAR |
| 2025-04-25 | Centessa Pharmaceuticals plc | Notice (144) Officer · Planned Apr 25, 2025 · 10b5-1 plan Sold: listed on the May 27, 2025 notice |
−11,742 | -$158.4K | EDGAR |
| 2025-04-25 | Centessa Pharmaceuticals plc (CNTA) Delisted | Sell (S)10b5-1 Plan adopted May 22, 2024 |
−11,742 | -$159.9K | EDGAR |
| 2025-03-26 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed10b5-1 Plan adopted May 22, 2024 |
— | -$124.9K | EDGAR |
| 2025-03-25 | Centessa Pharmaceuticals plc | Notice (144) Officer · Planned Mar 25, 2025 · 10b5-1 plan Sold: listed on the Apr 25, 2025 notice |
−10,000 | -$165.3K | EDGAR |
| 2025-02-26 | Centessa Pharmaceuticals plc (CNTA) Delisted | Sell (S)10b5-1 Plan adopted May 22, 2024 |
−11,494 | -$175.3K | EDGAR |
| 2025-02-25 | Centessa Pharmaceuticals plc | Notice (144) Officer · Planned Feb 25, 2025 · 10b5-1 plan Sold: listed on the Mar 25, 2025 notice |
−11,494 | -$175.3K | EDGAR |
| 2025-02-04 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed | −14,267 | -$241.4K | EDGAR |
| 2025-01-28 | Centessa Pharmaceuticals plc (CNTA) Delisted | Sell (S)10b5-1 Plan adopted May 22, 2024 |
−11,742 | -$193.4K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
15 sales · $4.93M| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2026-03-13 | Centessa Pharmaceuticals plc | 73,196 | $1.93M | $26.33 | 2026-03-26 |
| 2025-06-25 | Centessa Pharmaceuticals plc | 10,000 | $138.6K | $13.86 | 2025-07-25 |
| 2025-05-27 | Centessa Pharmaceuticals plc | 10,000 | $128.2K | $12.82 | 2025-06-25 |
| 2025-04-25 | Centessa Pharmaceuticals plc Seller: Gregory Weinhofff |
11,742 | $159.9K | $13.61 | 2025-05-27 |
| 2025-03-25 | Centessa Pharmaceuticals plc | 10,000 | $163.4K | $16.34 | 2025-04-25 |
| 2025-02-25 | Centessa Pharmaceuticals plc | 11,494 | $175.3K | $15.25 | 2025-03-25 |
| 2025-01-27 | Centessa Pharmaceuticals plc | 11,742 | $193.4K | $16.47 | 2025-02-25 |
| 2024-12-26 | Centessa Pharmaceuticals plc | 10,000 | $170.4K | $17.04 | 2025-01-27 |
| 2024-11-25 | Centessa Pharmaceuticals plc | 10,000 | $176.6K | $17.66 | 2024-12-26 |
| 2024-10-25 | Centessa Pharmaceuticals plc | 11,742 | $180.6K | $15.38 | 2024-11-25 |
| 2024-09-25 | Centessa Pharmaceuticals plc | 16,619 | $260.7K | $15.69 | 2024-10-25 |
| 2024-09-10 | Centessa Pharmaceuticals plc | 30,000 | $510.0K | $17.00 | 2024-09-25 |
| 2024-09-09 | Centessa Pharmaceuticals plc | 25,000 | $375.0K | $15.00 | 2024-09-10 |
| 2024-08-23 | Centessa Pharmaceuticals plc | 17,802 | $218.8K | $12.29 | 2024-09-09 |
| 2024-08-22 | Centessa Pharmaceuticals plc | 12,198 | $148.4K | $12.17 | 2024-08-23 |